IRTC (iRhythm Holdings) Current Accrued Expense: $157.6 Mil (As of Jun. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

IRTC iRhythm Holdings Inc IRTC
77 GF Score
Price $127.95
GF Value $153.91
Valuation Modestly Undervalued
! 1 Warning Sign
View Full Analysis

What is iRhythm Holdings Current Accrued Expense?

iRhythm Holdings IRTC +2.59% 77 Current Accrued Expense is $157.6 Mil as of Jun. 2026. GuruFocus rates IRTC with a GF Score™ of 77/100 and a GF Value™ of $153.91 (Modestly Undervalued). The stock has 1 warning sign investors should review.

iRhythm Holdings's Current Accrued Expense for the quarter that ended in Jun. 2026 was $157.6 Mil.

iRhythm Holdings's quarterly Current Accrued Expense declined from Dec. 2025 ($124.7 Mil) to Mar. 2026 ($102.3 Mil) but then increased from Mar. 2026 ($102.3 Mil) to Jun. 2026 ($157.6 Mil).

iRhythm Holdings's annual Current Accrued Expense increased from Dec. 2023 ($74.9 Mil) to Dec. 2024 ($78.3 Mil) and increased from Dec. 2024 ($78.3 Mil) to Dec. 2025 ($124.7 Mil).

iRhythm Holdings Current Accrued Expense Related Terms

iRhythm Holdings Current Accrued Expense Historical Data

* Premium members only.

The historical data trend for iRhythm Holdings's Current Accrued Expense can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

iRhythm Holdings Current Accrued Expense Chart

iRhythm Holdings Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Current Accrued Expense
Get a 7-Day Free Trial Premium Member Only Premium Member Only 47.50 57.60 74.87 78.30 124.73

iRhythm Holdings Quarterly Data
Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26 Jun26
Current Accrued Expense Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 95.25 112.06 124.73 102.34 157.57
IRTC
77GF Score
iRhythm Holdings Inc IRTC
Current Accrued Expense is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

iRhythm Holdings Current Accrued Expense Calculation

Current Accrued Expense is the expense incurred during the accounting period, but not required to be paid until a later date. It includes compensation, interest, pensions and all other miscellaneous accruals reported by the company.

What does a Current Accrued Expense of $157.6 Mil mean?
iRhythm Holdings (IRTC) has a Current Accrued Expense of $157.6 Mil as of Jun. 2026. Current Accrued Expense records the total amount of accrued expenses. View historical data on iRhythm Holdings and its competitors.
Is iRhythm Holdings' Current Accrued Expense too high?
iRhythm Holdings' current Current Accrued Expense is $157.6 Mil. Overall, iRhythm Holdings has a GF Score™ of 77/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does iRhythm Holdings' Current Accrued Expense compare to HAE and ITGR?
iRhythm Holdings' Current Accrued Expense of $157.6 Mil can be compared against companies in the Medical Devices & Instruments industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Current Accrued Expense for a Medical Devices & Instruments company?
A good Current Accrued Expense depends on the Medical Devices & Instruments industry context. However, Current Accrued Expense should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Current Accrued Expense mean?
A high Current Accrued Expense can signal that a stock is expensive relative to its fundamentals. Current Accrued Expense records the total amount of accrued expenses. View historical data on iRhythm Holdings and its competitors. iRhythm Holdings's current Current Accrued Expense is $157.6 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is iRhythm Holdings stock overvalued right now?
Based on GuruFocus' analysis, iRhythm Holdings (IRTC) is currently considered Modestly Undervalued. The stock's GF Value™ is $153.91, compared to a current price of $127.95 — trading 16.9% below its estimated fair value. The current Current Accrued Expense is $157.6 Mil. iRhythm Holdings' overall GF Score™ is 77/100 with 1 warning sign to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Current Accrued Expense calculated?
Current Accrued Expense is calculated from a company's financial statements. For iRhythm Holdings (IRTC), the current Current Accrued Expense is $157.6 Mil as of Jun. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is iRhythm Holdings (IRTC) Overvalued in 2026?

Based on GuruFocus' analysis, iRhythm Holdings stock appears to be undervalued. The current stock price of $127.95 is trading 16.9% below its estimated GF Value™ of $153.91. GuruFocus considers iRhythm Holdings to be Modestly Undervalued.

Key valuation signals for IRTC:

  • Current Accrued Expense: $157.6 Mil
  • GF Value™: $153.91 vs. price of $127.95 (16.9% below fair value)
  • GF Score™: 77/100 with 1 warning sign

No single metric tells the full story. See the IRTC stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

iRhythm Holdings Business Description

Other Exchanges 0A7L:UK
Address 699 8th Street, Suite 600, San Francisco, CA, USA, 94103
iRhythm Holdings Inc is a digital healthcare company that creates trusted solutions that detect, predict, and prevent disease. Its principal business is the design, development, and commercialization of device-based technology to provide ambulatory cardiac monitoring services that it believes allow clinicians to diagnose certain arrhythmias quicker and with greater efficiency than other services that rely on traditional technology. Each Zio System combines an FDA-cleared and CE-marked, wire-free, patch-based, 14-day wearable biosensor that continuously records electrocardiogram (ECG) data with a proprietary, FDA-cleared, CE-marked cloud-based data analytic software to help physicians monitor patients and diagnose arrhythmias.
77GF Score

Get the complete analysis for IRTC

Current Accrued Expense is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$127.95
Price
$153.91
GF Value